Anti-Infection Experience Analysis of a Patient with Bacillus cereus Lung Empyema Diagnosed by Targeted Next-Generation Sequencing (tNGS)
DOI:
https://doi.org/10.54097/6q1a1095Keywords:
Bacillus Cereus, tNGS Technology, Lung Empyema, Anti-infection, Clinical PhysiciansAbstract
Bacillus cereus is an aerobic, Gram-positive bacterium widely present in soil and food, causing human infections primarily through foodborne diseases, manifesting as abdominal pain, vomiting, and diarrhea. There are rare reports of it causing pulmonary infections domestically and internationally. This paper reports a case of lung empyema caused by Bacillus cereus diagnosed with the aid of targeted Next-Generation Sequencing (tNGS) technology. We retrospectively analyzed the diagnosis and treatment process of the patient and reviewed literature to enhance our understanding and treatment level of such diseases. Currently, there is no standard anti-infection treatment plan for lung empyema caused by Bacillus cereus. Clinical physicians, by understanding the epidemiological characteristics of this bacterium, consulting relevant literature, and combining the patient's clinical condition, tests, and related etiological results, adjusted the antimicrobial treatment to effectively control and treat the infection focus.
Downloads
References
[1] May FJ, Polkinghorne B, Fearnley E. Epidemiology of bacterial toxin-mediated foodborne gastroenteritis outbreaks in australia, 2001 to 2013. Commun Dis Intell Q Rep. Published online December 24, 2016.
[2] Chou YL, Cheng SN, Hsieh KH, Wang CC, Chen SJ, Lo WT. Bacillus cereus septicemia in a patient with acute lymphoblastic leukemia: A case report and review of the literature. J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. 2016;49(3):448-451. doi:10.1016/j.jmii.2013.06.010.
[3] Uchino Y, Iriyama N, Matsumoto K, et al. A case series of bacillus cereus septicemia in patients with hematological disease.Intern Med. 2012;51(19):2733-2738. doi:10.2169/ internalmedicine.51.7258.
[4] Drobniewski FA. Bacillus cereus and related species. Clin Microbiol Rev. 1993;6(4):324-338. doi:10.1128/CMR.6.4.324.
[5] Ba Y, Shi Y, Jiang W, et al. Current management of chemotherapy-induced neutropenia in adults: Key points and new challenges: committee of neoplastic supportive-care (CONS), China anti-cancer association committee of clinical chemotherapy, china anti-cancer association. Cancer Biol Med. 2020;17(4):896-909.doi:10.20892/j.issn.2095-941.2020.0069.
[6] Zhang P, Liu B, Zhang S, et al. Clinical application of targeted next-generation sequencing in severe pneumonia: A retrospective review. Crit Care Lond Engl. 2024;28(1):225. doi: 10. 1186/s13054-024-05009-8.
[7] Chen P, Sun W, He Y. Comparison of the next-generation sequencing (NGS) technology with culture methods in the diagnosis of bacterial and fungal infections. J Thorac Dis. 2020;12(9):4924. doi:10.21037/jtd-20-930.
[8] Glasset B, Herbin S, Granier SA, et al. Bacillus cereus, a serious cause of nosocomial infections: Epidemiologic and genetic survey. PloS One. 2018;13(5):e0194346. doi:10.1371/ journal.pone.0194346.
[9] Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: An overview and current issues. Infect Dis Clin North Am. 2016;30(3):609-637. doi:10.1016/j.idc.2016.04.002.
[10] Elsheikh A, Bhatnagar M, Rahman NM. Diagnosis and management of pleural infection. Breathe Sheff Engl. 2023;19(4):230146. doi:10.1183/20734735.0146-2023.
[11] Torkar KG, Bedenić B. Antimicrobial susceptibility and characterization of metallo-β-lactamases, extended-spectrum β-lactamases, and carbapenemases of bacillus cereus isolates. Microb Pathog. 2018;118:140-145. doi:10.1016/j.micpath. 2018.03.026.
[12] Frenzel E, Kranzler M, Stark TD, Hofmann T, Ehling-Schulz M. The endospore-forming pathogen bacillus cereus exploits a small colony variant-based diversification strategy in response to aminoglycoside exposure. mBio. 2015;6(6):10.1128/mbio. 01172-15. doi:10.1128/mbio.01172-15.
[13] Liu C, Yu P, Yu S, et al. Assessment and molecular characterization of bacillus cereus isolated from edible fungi in China. BMC Microbiol. 2020;20(1):310. doi:10.1186/s12866-020-01996-0.
[14] Andersson MA, Mikkola R, Helin J, Andersson MC, Salkinoja-Salonen M. A novel sensitive bioassay for detection of bacillus cereus emetic toxin and related depsipeptide ionophores. Appl Environ Microbiol. 1998;64(4):1338-1343. doi:10.1128/AEM. 64.4.1338-1343.1998.
[15] Tusgul S, Prod’hom G, Senn L, Meuli R, Bochud PY, Giulieri SG. Bacillus cereus bacteraemia: Comparison between haematologic and nonhaematologic patients. New Microbes New Infect. 2016;15:65. doi:10.1016/j.nmni.2016.11.011.
[16] Uchino Y, Iriyama N, Matsumoto K, et al. A case series of bacillus cereus septicemia in patients with hematological disease. Intern Med. 2012;51(19):2733-2738. doi:10.2169/ internalmedicine.51.7258.
[17] Chen CY, Huang SY, Tsay W, et al. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in taiwan, 2001-2010. Int J Antimicrob Agents. 2012;40(6): 533-538. doi:10.1016/j.ijantimicag.2012.07.022.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
